| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5541170 | APIL | Orally administrable pharmaceutical compositions |
Jul, 2013
(10 years ago) | |
| US5541171 | APIL | Orally administrable pharmaceutical composition |
Jul, 2013
(10 years ago) | |
Asacol is owned by Apil.
Asacol contains Mesalamine.
Asacol has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Asacol are:
- US5541170
- US5541171
Asacol was authorised for market use on 31 January, 1992.
Asacol is available in tablet, delayed release;oral dosage forms.
Asacol can be used as treatment of ulcerative colitis.
The generics of Asacol are possible to be released after 30 July, 2013.
Drugs and Companies using MESALAMINE ingredient
Market Authorisation Date: 31 January, 1992
Treatment: Treatment of ulcerative colitis
Dosage: TABLET, DELAYED RELEASE;ORAL
How can I launch a generic of ASACOL before it's drug patent expiration?
More Information on Dosage
ASACOL family patents
